News & Updates

Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.

Monthly injections of erenumab help induce and sustain remission of chronic migraine and medication overuse headaches, as shown in the phase IV INOVA study.

Short-term exposure to lower air temperature and cold spells may elevate the risk of hospitalization due to myocardial infarction (MI) at a lag of 2 to 6 days, suggests a study in Sweden.

Patients with cirrhosis who have a history of depression are at greater risk of developing hepatic encephalopathy, reveals a study.